Harvard stem cell scientists at Brigham and Women’s Hospital have pioneered a method using steroids to make mighty stem cells, increasing their usefulness for potential cell therapies.
Unlike sports, where performance-enhancing drugs are banned, in the cell therapy field, approaches that ‘pump up’ the potency of cells to make them more effective are being used. Harvard Stem Cell Institute Principal Faculty member, Jeffrey Karp, PhD, and postdoctoral fellow James Ankrum, PhD, developed a way to significantly and uniformly enhance stem cell performance by treating cells with a commonly used class of drugs called glucocorticoid steroids. Their work appears in Scientific Reports.
“Stem cells have the potential to treat nearly every disease imaginable from heart disease and osteoporosis to arthritis and multiple sclerosis,” said Karp. “But not all stem cells are equal and often cells that are infused into patients lack the required potency to have an impact. Without highly potent cells, high doses are needed, making stem cell therapy challenging, expensive and ineffective.”
The researchers treated mesenchymal stem cells (a type of stem cell that gives rise to the bone marrow tissue) with steroids to greatly increase their expression of an important anti-inflammatory factor, making the stem cells more potent compared to non-treated cells. Observing that the cells were most potent when they were being constantly exposed to steroids, the researchers then equipped the cells with microscopic reservoirs of the drug inside them, giving them continuous access to the steroids.
“We then placed these steroid-boosted stem cells in the presence of inflamed immune cells and saw that these enhanced cells were twice as potent as unmodified cells at stopping the inflammatory process,” said Ankrum. “Our approach enables fine tuning of cell potency and control following transplantation, which could lead to more successful cell-based therapies.”
The Latest on: Stem cell performance
[google_news title=”” keyword=”Stem cell performance” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Stem cell performance
- Stem cell transplants and survival rates on the rise across all racial and ethnic groupson April 25, 2024 at 7:00 am
The volume of hematopoietic cell transplants rose among all racial/ethnic groups, but grew faster among African Americans and Hispanics compared with non-Hispanic white individuals, mirroring changes ...
- Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s diseaseon April 25, 2024 at 6:00 am
Whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) could heal luminal ulcers in Crohn’s disease.
- New device improves stem cell generation and chance for accessible Alzheimer's cell therapyon April 24, 2024 at 12:11 pm
Researchers in Sweden say they have improved on a technique for converting regular skin cells into neural stem cells—an advance that they say helps close the gap for accessible personalized cell-based ...
- Brittany Higgins demands Australia declare a 'national emergency' into violence against women after spate of horrific killingson April 24, 2024 at 5:33 am
The former Liberal Party staffer turned activist shared a video from the Women's Agenda on Wednesday, which announced that rallies are to be held across the country this weekend. The 'No More' ...
- The 33 Best Natural Skincare Products in 2024on April 23, 2024 at 12:44 pm
Branded content. Us Weekly has affiliate partnerships so we may receive compensation for some links to products and services. One thing is for certain: Natural skincare is here to stay. Every year, ...
- Portuguese scientists create human stem cells to treat Machado-Joseph disease. What to knowon April 23, 2024 at 7:38 am
Portuguese scientists managed to create human stem cells from skin cells that have the potential for long-term treatment of Machado-Joseph disease.
- Stem cell shots and sim rigs: Why David Malukas' future with Arrow McLaren is unclearon April 23, 2024 at 1:31 am
David Malukas has missed 14 days in the car. Theo Pourchaire was Long Beach's biggest mover. 'We're having to make difficult decisions,' Gavin Ward said.
- Asia Pacific Stem Cell Therapy Market Anticipates US$ 3,420.05 Million Value by 2031on April 22, 2024 at 7:04 pm
The Asia Pacific Stem Cell Therapy Market is poised for substantial growth in the coming years, with a projected compound annual growth rate (CAGR) of 10.29% between 2023 and 2031. This growth is ...
- If It Rights the Ship, Harvard Can Inform a New Renaissanceon April 21, 2024 at 9:04 pm
The people who help earn its reputation, and the people who live off it. With a combination of grace and grit, we can all be the former.
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Resultson April 15, 2024 at 6:00 pm
Cryo-Cell International, Inc. (NYSE American LLC: CCEL ) (the “Company”), the world’s first private cord blood bank to separate and store stem cells i ...
via Bing News